Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration-Where Are We Now?
Publication

Publications

MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration-Where Are We Now?

Title
MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration-Where Are We Now?
Type
Another Publication in an International Scientific Journal
Year
2024
Authors
Ferreira, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Morais, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rui Medeiros
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Teixeira, AL
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: PharmaceuticsImported from Authenticus Search for Journal Publications
Vol. 16
Final page: 1347
ISSN: 1999-4923
Publisher: MDPI
Indexing
Publicação em ISI Web of Knowledge ISI Web of Knowledge - 0 Citations
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-017-DCQ
Abstract (EN): MicroRNAs are a conserved class of small, tissue-specific, non-coding RNAs that regulate gene expression to preserve cellular homeostasis. Proper miRNA expression is crucial for physiological balance because it affects numerous genetic pathways, including cell cycle control, proliferation, and apoptosis, through gene expression targeting. Deregulated miRNA expression has been implicated in several cancer types, including prostate cancer (PC), acting as tumor suppressors or oncogenes. Despite the availability of promising therapies to control tumor growth and progression, effective diagnostic and therapeutic strategies for different types of cancer are still lacking. PC continues to be a significant health challenge, particularly its castration-resistant (CRPC) form, which presents major therapeutic obstacles because of its resistance to conventional androgen deprivation treatments. This review explores miRNAs' critical roles in gene regulation and cancer biology, as well as various miRNA delivery systems, highlighting their potential and the challenges in effectively targeting cancer cells. It aims to provide a comprehensive overview of the status of miRNA research in the fight against CRPC, summarizing miRNA-based therapies' successes and limitations. It also highlights the promise of miRNAs as therapeutic agents for CRPC, underlining the need for further research to overcome existing challenges and move these therapies toward clinical applications.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 23
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Second-Generation Antimitotics in Cancer Clinical Trials (2021)
Another Publication in an International Scientific Journal
Novais, P; Silva, PMA; Maria Isabel Amorim; Bousbaa, H
Research Models to Study Ferroptosis's Impact in Neurodegenerative Diseases (2023)
Another Publication in an International Scientific Journal
Fernanda Borges
Red Seaweed-Derived Compounds as a Potential New Approach for Acne Vulgaris Care (2021)
Another Publication in an International Scientific Journal
Januario, AP; Felix, R; Felix, C; Reboleira, J; Patricia Valentao; Lemos, MFL
Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies (2020)
Another Publication in an International Scientific Journal
Teixeira, MI; Maria Helena Amaral; Paulo Costa; Lopes, CM; Lamprou, DA
Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence (2020)
Another Publication in an International Scientific Journal
Menditto, E; Orlando, V; De Rosa, G; Minghetti, P; Musazzi, UM; Cahir, C; Kurczewska Michalak, M; Kardas, P; Costa, E; Sousa Lobo JM; Almeida, IF

See all (107)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-19 at 04:30:31 | Privacy Policy | Personal Data Protection Policy | Whistleblowing